Cargando…

Editorial: Engineered immune cells in cancer immunotherapy (EICCI)

Detalles Bibliográficos
Autores principales:	Martin, Francisco, Schambach, Axel, Maccalli, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809271/ https://www.ncbi.nlm.nih.gov/pubmed/36605186 http://dx.doi.org/10.3389/fimmu.2022.1119363

Ejemplares similares

Proceedings From the First International Workshop at Sidra Medicine: “Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development”, 15(th)–16(th) February 2019, Doha, Qatar
por: Guerrouahen, Bella, et al.
Publicado: (2021)

Editorial: Translation of genetically engineered T cells in cancer immunotherapy
por: Voss, Ralf-Holger, et al.
Publicado: (2023)

Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy
por: Bazhin, Alexandr V., et al.
Publicado: (2018)

Editorial: Extracellular traps in cancer immunity and immunotherapy
por: Rahat, Michal A., et al.
Publicado: (2023)

Editorial: Adenosine pathways in cancer immunity and immunotherapy
por: Fu, Junjiang, et al.
Publicado: (2023)

Editorial: NK Cell-Based Cancer Immunotherapy
por: Borrego, Francisco, et al.
Publicado: (2016)

Cancer Immunotherapy Using Chimeric Antigen Receptor Expressing T-Cells: Present and Future Needs of Clinical Cancer Centers
por: Gotti, Manuel, et al.
Publicado: (2020)

Engineering CAR-T Cells for Improved Function Against Solid Tumors
por: Morgan, Michael A., et al.
Publicado: (2018)

Immune Profiling of Cancer Patients Treated with Immunotherapy: Advances and Challenges
por: Pilla, Lorenzo, et al.
Publicado: (2018)

Editorial: Targeting glucose metabolism in cancer immunity and immunotherapy
por: Feron, Olivier, et al.
Publicado: (2023)

Editorial: Emerging talents in cancer immunity and immunotherapy: 2022
por: Maeurer, Markus
Publicado: (2023)

Editorial: Rising stars in cancer immunity and immunotherapy 2022
por: Goyvaerts, Cleo, et al.
Publicado: (2023)

Editorial: NKT Cells in Cancer Immunotherapy
por: Webb, Tonya J., et al.
Publicado: (2020)

Editorial: Post-translational modifications of proteins in cancer immunity and immunotherapy
por: Dai, Xiangpeng, et al.
Publicado: (2022)

Editorial: Updates on toll-like receptors in cancer immunity and immunotherapy
por: Hoden, Bettina, et al.
Publicado: (2023)

Reverting Immune Suppression to Enhance Cancer Immunotherapy
por: Guerrouahen, Bella S., et al.
Publicado: (2020)

Editorial: The relationship between COVID-19 severity and cancer immunity and immunotherapy
por: Nunès, Jacques A., et al.
Publicado: (2023)

Erratum: Editorial: NKT Cells in Cancer Immunotherapy
Publicado: (2020)

Editorial: CD4(+) T Cells in Cancer Immunotherapies
por: González-Navajas, José M., et al.
Publicado: (2021)

Editorial: Non-coding RNA in immunotherapies and immune regulation
por: Kaeffer, Bertrand, et al.
Publicado: (2022)

Editorial: Heterologous Immunity: Implications and Applications in Vaccines and Immunotherapies
por: Singh, Shakti, et al.
Publicado: (2020)

Editorial: Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms
por: Lafont, Virginie, et al.
Publicado: (2021)

Editorial: Crosstalk between innate and adaptive immunity in colorectal cancer: Implications for immunotherapy
por: Jarry, Anne, et al.
Publicado: (2023)

Editorial: “Cancer Immunotherapy: Lights and Shadows”
por: Barrio, María Marcela, et al.
Publicado: (2015)

Editorial: Targeting Metabolism in Cancer Immunotherapy
por: Roszik, Jason, et al.
Publicado: (2018)

Editorial: The role of multi-omics variants in tumor immunity and immunotherapy
por: Chen, Shuang, et al.
Publicado: (2022)

Editorial: The challenge of immunity evaluation and immunotherapy in gynecologic and urologic oncology
por: Tan, Ruirong, et al.
Publicado: (2023)

Editorial: Interplay between oncomicrobes, the microbiota and the immune system: impact on responses to cancer immunotherapy
por: Dorta-Estremera, Stephanie M., et al.
Publicado: (2023)

T Cell Dysfunction in Cancer Immunity and Immunotherapy
por: Xia, Anliang, et al.
Publicado: (2019)

Editorial: Nanobody-based cancer immunotherapy and immunoimaging
por: Jafari, Mahdie, et al.
Publicado: (2023)

Editorial: The Spectrum of Lymphoid Subsets in Allergic Diseases: Immune Regulation and Immunotherapy
por: Liu, Zheng, et al.
Publicado: (2022)

Editorial: Immune Outposts on the Inflammatory Frontier: Tertiary Lymphoid Structures as Targets for Immunotherapy of Cancer and Autoimmunity
por: Silina, Karina, et al.
Publicado: (2019)

Editorial: Advances in Human Immune System Mouse Models for Studying Human Hematopoiesis and Cancer Immunotherapy
por: Saito, Yasuyuki, et al.
Publicado: (2021)

Editorial: Community series in post-translational modifications of proteins in cancer immunity and immunotherapy, volume II
por: Nihira, Naoe Taira, et al.
Publicado: (2023)

Editorial: The immunosuppressive tumor microenvironment and strategies to revert its immune regulatory milieu for cancer immunotherapy
por: Ganjalikhani Hakemi, Mazdak, et al.
Publicado: (2023)

Engineering Approaches in Human Gamma Delta T Cells for Cancer Immunotherapy
por: Fisher, Jonathan, et al.
Publicado: (2018)

Editorial: Understanding the Cytokine Release Syndrome: Toward Improving Cancer Immunotherapy
por: Martín-Antonio, Beatriz
Publicado: (2021)

Editorial: NK cells in viral immunology and immunotherapy
por: Mulik, Sachin, et al.
Publicado: (2023)

Editorial: Immunotherapy in Multiple Myeloma
por: Giuliani, Nicola, et al.
Publicado: (2019)

Editorial: Immune Responses to Persistent or Recurrent Antigens: Implications for Immunological Memory and Immunotherapy
por: Caserta, Stefano, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_01e26t0mdci4km97ton2e2t58f